| View |
2020-05-29-0149
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
BR-629
|
19URAB096
|
Packaging Lot: Box & vial - 19URAB096; ampoule (diluent) - SCSVBA1519 (MD: 09/19; ED: 08/23); Syringe (2mL) - 1906501 (MD: 2019-06; ED: 2024-05)
|
31 October 2022
|
01 June 2020
|
| View |
2020-07-23-0204
|
Hepatitis A (Inactivated) Vaccine (Adsorbed)
|
Havrix 720
|
BR-1303
|
AHAVC042A
|
Packaging lot (box & pfs): AHAVC042AC
Needle(25Gx5/8”): 1912035 ED: 2024-11-30
|
31 October 2022
|
27 July 2020
|
| View |
2021-02-10-0055
|
RECOMBINANT HUMAN ERYTHROPOIETIN
|
WEPOX 4000
|
BR-545
|
DV11037
|
Packaging Lot: DV11037
|
31 October 2022
|
08 April 2021
|
| View |
2021-02-10-0059
|
Inactivated Poliomyelitis Vaccine (Type 1, 2 and 3)
|
IMOVAX POLIO
|
BR-929
|
T1F88
|
Packaging Lot (Box): T1F881; (Vial): T1F88
|
31 October 2022
|
15 February 2021
|
| View |
2021-03-02-0096
|
Vi-polysaccharide Typhoid Vaccine
|
TYPHIM VI
|
BR-280
|
T2B22
|
Packaging Lot (Box): T2B224V; 72B22
|
31 October 2022
|
04 March 2021
|
| View |
2021-05-11-0211
|
MEASLES, MUMPS, RUBELLA (MMR) VACCINE (LIVE, ATTENUATED) [HUMAN SERUM ALBUMIN FREE]
|
PRIORIX
|
BR-415
|
A69CF241A
|
Packaging Lot (Box): A69CF241A; (Vial): A69FF241A; (Pre- Filled Syringe): A69DF241A; (Needle): (25G x 5/8'') - 2005039
|
31 October 2022
|
14 May 2021
|
| View |
2021-05-24-0235
|
INSULIN GLARGINE
|
GLARITUS
|
BRP-037
|
DV10193
|
Packaging lot (Box & Pen): DV10193
|
31 October 2022
|
27 May 2021
|
| View |
2021-05-24-0236
|
INSULIN GLARGINE
|
GLARITUS
|
BRP-037
|
DV10194
|
Packaging lot (Box & Pen): DV10194
|
31 October 2022
|
27 May 2021
|
| View |
2021-02-10-0061
|
INSULIN GLARGINE
|
GLYSOLIN G
|
BRP-037-01
|
DV11007
|
Packaging Lot (Box & Pen): DV11007
|
31 October 2023
|
31 March 2021
|
| View |
2021-02-10-0062
|
INSULIN GLARGINE
|
GLARITUS
|
BRP-037
|
DV10981
|
Packaging Lot (Box & Pen): DV10981
|
31 October 2023
|
31 March 2021
|
| View |
2021-08-11-0409
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161W005
|
Packaging Lot (Box & Vial): 0161W005; (Ampoule): Diluent - Lot1: 0680S1217, Lot2: 0680S1218
|
31 October 2023
|
13 August 2021
|
| View |
2021-08-11-0410
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
BR-911
|
0161W006
|
Packaging Lot (Box & Vial): 0161W006; (Ampoule): Diluent - Lot1: 0680S1217, Lot2: 0680S1218
|
31 October 2023
|
13 August 2021
|
| View |
2021-08-11-0411
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
-
|
FDA-0187303
|
0161N007
|
Packaging Lot (Box & Vial): 0161N007; (Diluent 1): 0680S1217; (Diluent 2): 0680S1218
|
31 October 2023
|
16 August 2021
|
| View |
2021-11-23-0531
|
PNEUMOCOCCAL CONJUGATE VACCINE, 13-VALENT (ADSORBED)
|
PREVENAR 13
|
BR-1133
|
ED8314
|
Packaging Lot (Box & Pre-filled Syringe): FJ0067; (Needle 25G): 2104031
|
31 October 2023
|
25 November 2021
|
| View |
2022-03-04-0055
|
PNEUMOCOCCAL CONJUGATE VACCINE, 13-VALENT (ADSORBED)
|
PREVENAR 13
|
BR-1133
|
ED8313
|
Packaging Lot (Box & Pre-filled Syringe): FL4242; (Needle 25G x 1"): 2107018
|
31 October 2023
|
9 March 2022
|
| View |
2022-04-07-0090
|
MEASLES, MUMPS, RUBELLA (MMR) VACCINE (LIVE, ATTENUATED)
|
PRIORIX
|
BR-415
|
A69CF382A
|
Packaging Lot (Box ): A69CF382A; (Vial): A69FF382A; (Pre-filled Syringe): A69DF382A; (Needle 25G x 5/8"): 2102019
|
31 October 2023
|
12 April 2022
|
| View |
2022-07-07-0178
|
BCG VACCINE
|
-
|
BR-572
|
0371G090
|
Packaging Lot (Box & Vial): 0371G109; (Ampoule [diluent]): 0640S4037
|
31 October 2023
|
12 July 2022
|
| View |
2021-09-17-0475
|
MENINGOCOCCAL GROUP A, C, W-135, AND Y CONJUGATE VACCINE
|
NIMENRIX
|
BR-924
|
AMECA116A
|
Packaging Lot (Vial): FF3606; (Diluent): AD02A157A
|
31 October 2024
|
21 September 2021
|
| View |
2022-09-29-0270
|
LIVE ATTENUATED MEASLES, MUMPS AND RUBELLA VACCINE
|
TRESIVAC
|
BR-434
|
0131N090A
|
Packaging Lot (Box & Vial): 0131N090A; (Diluent): 0640S4031
|
31 October 2024
|
6 October 2022
|
| View |
2022-12-12-0356
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03322002
|
Packaging Lot (Box & Vial): A03322002
|
31 October 2024
|
16 December 2022
|